# Alexanders Inc: financial statements, quarterly

ALX · NYSE · CIK 3499 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/alx.md) · [Financials](/companies/alx/financials.md) · [Filings](/companies/alx/filings.md) · [Insiders](/companies/alx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/alx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [55.4](/filings/0000003499-24-000041.md) | [62.9 d](/filings/0000003499-26-000005.md) | [61.4](/filings/0000003499-25-000009.md) | [53.4](/filings/0000003499-25-000020.md) | [55.7](/filings/0000003499-25-000026.md) | [55.9 d](/filings/0000003499-26-000005.md) | [54.9](/filings/0000003499-26-000020.md) | [51.6](/filings/0000003499-26-000038.md) | [53.4](/filings/0000003499-25-000026.md) | [53.3 d](/filings/0000003499-26-000005.md) | [53.4](/filings/0000003499-26-000020.md) | [54.7](/filings/0000003499-26-000038.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [10.8](/filings/0000003499-24-000041.md) | [16.3 d](/filings/0000003499-26-000005.md) | [16.1](/filings/0000003499-25-000009.md) | [8.4](/filings/0000003499-25-000020.md) | [6.7](/filings/0000003499-25-000026.md) | [12.3 d](/filings/0000003499-26-000005.md) | [12.3](/filings/0000003499-26-000020.md) | [6.1](/filings/0000003499-26-000038.md) | [6.0](/filings/0000003499-25-000026.md) | [3.8 d](/filings/0000003499-26-000005.md) | [4.7](/filings/0000003499-26-000020.md) | [155](/filings/0000003499-26-000038.md) |
| Diluted EPS | $ per share | [2.10](/filings/0000003499-24-000041.md) | not reported | [3.14](/filings/0000003499-25-000009.md) | [1.63](/filings/0000003499-25-000020.md) | [1.30](/filings/0000003499-25-000026.md) | not reported | [2.40](/filings/0000003499-26-000020.md) | [1.19](/filings/0000003499-26-000038.md) | [1.16](/filings/0000003499-25-000026.md) | not reported | [0.91](/filings/0000003499-26-000020.md) | [30.24](/filings/0000003499-26-000038.md) |
| Basic EPS | $ per share | [2.10](/filings/0000003499-24-000041.md) | not reported | [3.14](/filings/0000003499-25-000009.md) | [1.63](/filings/0000003499-25-000020.md) | [1.30](/filings/0000003499-25-000026.md) | not reported | [2.40](/filings/0000003499-26-000020.md) | [1.19](/filings/0000003499-26-000038.md) | [1.16](/filings/0000003499-25-000026.md) | not reported | [0.91](/filings/0000003499-26-000020.md) | [30.24](/filings/0000003499-26-000038.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [508](/filings/0000003499-24-000041.md) | [532](/filings/0000003499-26-000005.md) | [526](/filings/0000003499-25-000009.md) | [411](/filings/0000003499-25-000020.md) | [355](/filings/0000003499-25-000026.md) | [339](/filings/0000003499-26-000038.md) | [320](/filings/0000003499-26-000020.md) | [313](/filings/0000003499-26-000038.md) | [286](/filings/0000003499-25-000026.md) | [128](/filings/0000003499-26-000038.md) | [76.2](/filings/0000003499-26-000020.md) | [303](/filings/0000003499-26-000038.md) |
| Total assets | $m | [1,411](/filings/0000003499-23-000030.md) | [1,404](/filings/0000003499-25-000004.md) | [1,391](/filings/0000003499-24-000015.md) | [1,481](/filings/0000003499-24-000030.md) | [1,365](/filings/0000003499-24-000041.md) | [1,341](/filings/0000003499-26-000005.md) | [1,333](/filings/0000003499-25-000009.md) | [1,321](/filings/0000003499-25-000020.md) | [1,296](/filings/0000003499-25-000026.md) | [1,111](/filings/0000003499-26-000038.md) | [1,096](/filings/0000003499-26-000020.md) | [1,203](/filings/0000003499-26-000038.md) |
| Total liabilities | $m | [1,159](/filings/0000003499-23-000030.md) | [1,166](/filings/0000003499-25-000004.md) | [1,161](/filings/0000003499-24-000015.md) | [1,268](/filings/0000003499-24-000030.md) | [1,174](/filings/0000003499-24-000041.md) | [1,164](/filings/0000003499-26-000005.md) | [1,170](/filings/0000003499-25-000009.md) | [1,175](/filings/0000003499-25-000020.md) | [1,168](/filings/0000003499-25-000026.md) | [1,002](/filings/0000003499-26-000038.md) | [1,006](/filings/0000003499-26-000020.md) | [979](/filings/0000003499-26-000038.md) |
| Shareholders' equity | $m | [252](/filings/0000003499-24-000041.md) | [238](/filings/0000003499-26-000005.md) | [230](/filings/0000003499-25-000020.md) | [213](/filings/0000003499-25-000026.md) | [191](/filings/0000003499-25-000026.md) | [177](/filings/0000003499-26-000038.md) | [163](/filings/0000003499-26-000038.md) | [145](/filings/0000003499-26-000038.md) | [128](/filings/0000003499-25-000026.md) | [109](/filings/0000003499-26-000038.md) | [90.7](/filings/0000003499-26-000038.md) | [224](/filings/0000003499-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.5) d](/filings/0000003499-24-000041.md) | [44.7 d](/filings/0000003499-26-000005.md) | [16.8](/filings/0000003499-25-000009.md) | [11.5 d](/filings/0000003499-25-000020.md) | [(5.0) d](/filings/0000003499-25-000026.md) | [30.8 d](/filings/0000003499-26-000005.md) | [15.7](/filings/0000003499-26-000020.md) | [43.6 d](/filings/0000003499-26-000038.md) | [(9.3) d](/filings/0000003499-25-000026.md) | [23.4 d](/filings/0000003499-26-000005.md) | [6.8](/filings/0000003499-26-000020.md) | [6.2 d](/filings/0000003499-26-000038.md) |
| Dividends paid | $m | [23.1 d](/filings/0000003499-24-000041.md) | [23.1 d](/filings/0000003499-26-000005.md) | [23.1](/filings/0000003499-25-000009.md) | [23.1 d](/filings/0000003499-25-000020.md) | [23.1 d](/filings/0000003499-25-000026.md) | [23.1 d](/filings/0000003499-26-000005.md) | [23.1](/filings/0000003499-26-000020.md) | [23.1 d](/filings/0000003499-26-000038.md) | [23.1 d](/filings/0000003499-25-000026.md) | [23.1 d](/filings/0000003499-26-000005.md) | [23.1](/filings/0000003499-26-000020.md) | [23.1 d](/filings/0000003499-26-000038.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,127](/filings/0000003499-23-000030.md) | [5,127](/filings/0000003499-24-000015.md) | [5,129](/filings/0000003499-24-000030.md) | [5,131](/filings/0000003499-24-000041.md) | [5,131](/filings/0000003499-25-000009.md) | [5,132](/filings/0000003499-25-000020.md) | [5,134](/filings/0000003499-25-000026.md) | [5,134](/filings/0000003499-26-000020.md) | [5,135](/filings/0000003499-26-000038.md) | [5,136](/filings/0000003499-25-000026.md) | [5,136](/filings/0000003499-26-000020.md) | [5,138](/filings/0000003499-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,107,290 at 2026-07-31, from the cover of the [10-Q filed 2026-08-03](/filings/0000003499-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.